In 2024, the GI Research Foundation Awards $600,000 for Novel Research Projects Led by Investigators at the University of Chicago


Millions of people in the United States are suffering from digestive diseases and cancers. Supporting innovative research to discover better treatments, prevention pathways, and cures is core to the GastroIntestinal (GI) Research Foundation’s mission.

Providing early “seed” money to bold ideas allows our funded scientists to take risks that could yield big rewards for patient treatment and outcomes.  These early investments often position our funded researchers to receive significant grant awards from more traditional funding sources like the National Institutes of Health which requires proof of concept before they can fund.

Click on each award to learn more about the problem the research will address, the hypothesis, the research plan, and the goals of improved patient care and outcomes.

Research on Inflammatory Bowel Disease (IBD) – Crohn’s and Ulcerative Colitis – and its complications received five of eight awards.

One unique aspect of the GI Research Foundation is its funding of research on a broad range of digestive diseases, including pancreatic cancer and liver diseases. Three awards support research in these areas.


Research Grant Summaries page